SOX9 Human siRNA Oligo Duplex (Locus ID 6662)
CAT#: SR304532
SOX9 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Need single siRNA in bulk?
Get a free quote
CNY 4,090.00
货期*
4周
规格
Cited in 4 publications. |
Product images
经常一起买 (3)
SOX9 mouse monoclonal antibody, clone OTI2H10 (formerly 2H10)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Purity | HPLC purified |
Quality Control | Tested by ESI-MS |
Sequences | Available with shipment |
Stability | One year from date of shipment when stored at -20°C. |
# of transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
Note | Single siRNA duplex (10nmol) can be ordered. |
Reference Data | |
RefSeq | NM_000346 |
Synonyms | CMD1; CMPD1; SRA1; SRXX2; SRXY10 |
Components | SOX9 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each (Locus ID 6662)Included - SR30004, Trilencer-27 Universal Scrambled Negative Control siRNA Duplex - 2 nmolIncluded - SR30005, RNAse free siRNA Duplex Resuspension Buffer - 2 ml |
Summary | The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal. [provided by RefSeq, Jul 2008] |
Performance Guranteed | OriGene guarantees that at least two of the three Dicer-Substrate duplexes in the kit will provide at least 70% or more knockdown of the target mRNA when used at 10 nM concentration by quantitative RT-PCR when the TYE-563 fluorescent transfection control duplex (cat# SR30002) indicates that >90% of the cells have been transfected and the HPRT positive control (cat# SR30003) provides 90% knockdown efficiency. For non-conforming siRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the siRNA kit. To arrange for a free replacement with newly designed duplexes, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled siRNA control (quantitative RT-PCR data required). |
Citations (4)
The use of this RNAi has been cited in the following citations: |
---|
Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis
,Kaushik, G;Seshacharyulu, P;Rauth, S;Nallasamy, P;Rachagani, S;Nimmakayala, RK;Vengoji, R;Mallya, K;Chirravuri-Venkata, R;Singh, AB;Foster, JM;Ly, QP;Smith, LM;Lele, SM;Malafa, MP;Jain, M;Ponnusamy, MP;Batra, SK;,
Oncogene
,PubMed ID 33288882
[SOX9]
|
SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells
,Ashkenazi, S;Ortenberg, R;Besser, M;Schachter, J;Markel, G;,
Oncotarget
,PubMed ID 26885752
[SOX9]
|
Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells
,Ikhapoh, IA;Pelham, CJ;Agrawal, DK;,
Differentiation
,PubMed ID 25913202
[SOX9]
|
In vitro osteogenic potential of human bone marrow derived MSCs is predicted by Runx2/Sox9 Ratio
,Loebel, C;Czekanska, E;Bruderer, M;Salzmann, GM;Alini, M;Stoddart, MJ;,
Tissue Eng Part A July 2014
,PubMed ID 24980654
[SOX9]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...